The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
Gespeichert in:
Middleton, L.S., et al., The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Addiction, Vol. 106, no. 8 (2011), p. 1460-1473.
Ref.
180338
Standort:
SIIS R.696 Archivo
Palabras clave:
Buprenorfina, Drogodependencias, Efectos, Fármacos, Opiáceos
Buprenorfina, Drogodependencias, Efectos, Fármacos, Opiáceos
Ähnliche Einträge: The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers
- PHARMACOKINETICS OF THE COMBINATION TABLET OF BUPRENORPHINE AND NALOXONE
- THRICE WEEKLY SUPERVISED DOSING WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET IS PREFERRED TO DAILY SUPERVISED DOSING BY OPIOID-DEPENDET HUMANS
- EFFICACY OF DAILY AND ALTERNATE-DAY DOSING REGIMENS WITH THE COMBINATION BUPRENORPHINE-NALOXONE TABLET
- EFFECTS OF BUPRENORPHINE AND NALOXONE IN MORPHINE-STABILIZED OPIOID ADDICTS
- A PILOT STUDY OF BUPRENORPHINE-NALOXONE COMBINATION TABLET (SUBOXONE) IN TREATMENT OF OPIOID DEPENDENCE
- PHARMACODYNAMICS OF DIAZEPAM CO ADMINISTERED WITH METHADONE OR BUPRENORPHINE UNDER HIGH DOSE CONDITIONS IN OPIOID DEPENDENT PATIENTS